Latest News by Industry
ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported a loss of $1.9 million in its second quarter.
On a per-share basis, the Alachua, Florida-based company said it had a loss of 4 cents. Earnings, adjusted for stock option expense, were 5 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.
The regenerative medicine company posted revenue of $47.9 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $43.3 million.
AxoGen expects full-year revenue in the range of $182 million to $186 million.
AxoGen shares have climbed 16% since the beginning of the year. The stock has decreased slightly more than 4% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGN